Pfizer’s Sutent kidney cancer win should give it a boost, at least until I-O treatments arrive

17th November 2017 Uncategorised 0

Pfizer’s old dog Sutent has shown it has one more trick to perform as a renal cancer treatment before being passed up by the new breed of immuno-oncology drugs.

More: Pfizer’s Sutent kidney cancer win should give it a boost, at least until I-O treatments arrive
Source: fierce